Stevanato Group S.p.A. (STVN) is a publicly traded company in the Healthcare sector, operating within the Medical - Instruments & Supplies industry. The company is headquartered in Piombino Dese, PD, Italy. The current CEO is Franco Stevanato.
STVN has IPO date of 2021-07-16, 5,521 full-time employees, listed on the NYSE, a market capitalization of $4.03B.
Stevanato Group S.p.A. is an Italian manufacturer and provider of integrated solutions for the pharmaceutical and healthcare industries. Founded in 1949 and based in Piombino Dese, the company designs, produces, and distributes a comprehensive portfolio of products including glass containment solutions, drug delivery systems, medical devices, diagnostic services, and specialized machinery for visual inspection, assembly, packaging, and glass forming. With deep expertise across the pharmaceutical supply chain, Stevanato serves global healthcare customers requiring high-quality, regulated solutions. The company operates as a subsidiary of Stevanato Holding S.R.L.
